Business Description
Genenta Science SPA
ISIN : US36870W1009
Share Class Description:
GNTA: ADRTotal Employee Number:
9Description
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.7 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | -1.16 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 18 | |||||
3-Year EPS without NRI Growth Rate | 20.3 | |||||
3-Year FCF Growth Rate | 5.2 | |||||
3-Year Book Growth Rate | -18.3 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 27.06 | |||||
9-Day RSI | 42.39 | |||||
14-Day RSI | 49.9 | |||||
3-1 Month Momentum % | 194.54 | |||||
6-1 Month Momentum % | 44.68 | |||||
12-1 Month Momentum % | -48.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 14.15 | |||||
Quick Ratio | 14.15 | |||||
Cash Ratio | 13.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -42.17 | |||||
ROA % | -28.7 | |||||
ROIC % | -376.94 | |||||
3-Year ROIIC % | 34153.85 | |||||
ROC (Joel Greenblatt) % | -19423.53 | |||||
ROCE % | -31.72 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 1.4 | |||||
Price-to-Tangible-Book | 1.4 | |||||
EV-to-EBIT | -1.65 | |||||
EV-to-EBITDA | -1.65 | |||||
EV-to-Forward-Revenue | 14.79 | |||||
EV-to-FCF | -1.59 | |||||
| Price-to-Net-Current-Asset-Value | 1.55 | |||||
| Price-to-Net-Cash | 1.7 | |||||
Earnings Yield (Greenblatt) % | -60.61 | |||||
FCF Yield % | -22.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GNTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genenta Science SPA Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.387 | ||
| Beta | 0.3792 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.31 | ||
| Volatility % | 118.4 | ||
| 14-Day RSI | 49.9 | ||
| 14-Day ATR ($) | 0.191742 | ||
| 20-Day SMA ($) | 1.77925 | ||
| 12-1 Month Momentum % | -48.74 | ||
| 52-Week Range ($) | 0.55 - 10 | ||
| Shares Outstanding (Mil) | 23.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genenta Science SPA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genenta Science SPA Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-06-29 17:00 | 1.81 (+6.47%) | ||
| Annual report for 2025 | 2026-04-01 | 0.67 (+8.65%) | ||
| General meeting for 2025 | 2025-04-29 17:00 | 4.08 (-0.49%) | ||
| Annual report for 2024 | 2025-03-28 | 3.98 (+0.76%) | ||
| Guidance call for 2024 | 2024-10-15 | 5.80 (-3.17%) | ||
| Guidance call for 2024 | 2024-08-05 | 4.03 (-2.42%) |
Show
Entries
Genenta Science SPA Frequently Asked Questions
What is Genenta Science SPA(GNTA)'s stock price today?
The current price of GNTA is $1.53. The 52 week high of GNTA is $10.00 and 52 week low is $0.55.
When is next earnings date of Genenta Science SPA(GNTA)?
The next earnings date of Genenta Science SPA(GNTA) is .
Does Genenta Science SPA(GNTA) pay dividends? If so, how much?
Genenta Science SPA(GNTA) does not pay dividend.
Guru Commentaries on NAS:GNTA
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE | 2025-01-08 |
Articles on Genenta Science SPA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers